• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 相关呼吸衰竭危重症患者 90 天死亡率的临床转归和独立危险因素:土耳其重症监护室的多中心研究。

Clinical Outcomes and Independent Risk Factors for 90-Day Mortality in Critically Ill Patients with Respiratory Failure Infected with SARS-CoV-2: A Multicenter Study in Turkish Intensive Care Units.

机构信息

Division of Intensive Care Medicine, Department of Internal Medicine, Erciyes University School of Medicine, Kayseri, Turkey.

Division of Intensive Care Medicine, Department of Internal Medicine, Pamukkale University School of Medicine, Denizli, Turkey.

出版信息

Balkan Med J. 2021 Sep;38(5):296-303. doi: 10.5152/balkanmedj.2021.21188.

DOI:10.5152/balkanmedj.2021.21188
PMID:34558415
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8880837/
Abstract

BACKGROUND

There are limited data on the long-term outcomes of COVID-19 from different parts of the world.

AIMS

To determine risk factors of 90-day mortality in critically ill patients in Turkish intensive care units (ICUs), with respiratory failure.

STUDY DESIGN

Retrospective, observational cohort.

METHODS

Patients with laboratory-confirmed COVID-19 and who had been followed up in the ICUs with respiratory failure for more than 24 hours were included in the study. Their demographics, clinical characteristics, laboratory variables, treatment protocols, and survival data were recorded.

RESULTS

A total of 421 patients were included. The median age was 67 (IQR: 57-76) years, and 251 patients (59.6%) were men. The 90-day mortality rate was 55.1%. The factors independently associated with 90-day mortality were invasive mechanical ventilation (IMV) (HR 4.09 [95% CI: [2.20-7.63], P < .001), lactate level >2 mmol/L (2.78 [1.93-4.01], P < .001), age ≥60 years (2.45 [1.48-4.06)], P < .001), cardiac arrhythmia during ICU stay (2.01 [1.27-3.20], P = .003), vasopressor treatment (1.94 [1.32-2.84], P = .001), positive fluid balance of ≥600 mL/day (1.68 [1.21-2.34], P = .002), PaO2/FiO2 ratio of ≤150 mmHg (1.66 [1.18-2.32], P = .003), and ECOG score ≥1 (1.42 [1.00-2.02], P = .050).

CONCLUSION

Long-term mortality was high in critically ill patients with COVID-19 hospitalized in intensive care units in Turkey. Invasive mechanical ventilation, lactate level, age, cardiac arrhythmia, vasopressor therapy, positive fluid balance, severe hypoxemia and ECOG score were the independent risk factors for 90-day mortality.

摘要

背景

关于 COVID-19 在世界不同地区的长期结局,数据有限。

目的

确定在土耳其重症监护病房(ICU)中患有呼吸衰竭的危重症 COVID-19 患者 90 天死亡率的危险因素。

研究设计

回顾性、观察性队列研究。

方法

纳入在 ICU 中因呼吸衰竭接受治疗且持续时间超过 24 小时的实验室确诊 COVID-19 患者。记录他们的人口统计学、临床特征、实验室变量、治疗方案和生存数据。

结果

共纳入 421 名患者。中位年龄为 67(IQR:57-76)岁,251 名患者(59.6%)为男性。90 天死亡率为 55.1%。与 90 天死亡率独立相关的因素包括有创机械通气(IMV)(HR 4.09[95%CI:[2.20-7.63],P<0.001)、乳酸水平>2mmol/L(2.78[1.93-4.01],P<0.001)、年龄≥60 岁(2.45[1.48-4.06],P<0.001)、ICU 期间出现心律失常(2.01[1.27-3.20],P=0.003)、血管加压素治疗(1.94[1.32-2.84],P=0.001)、每日正性液体平衡量≥600mL(1.68[1.21-2.34],P=0.002)、PaO2/FiO2 比值≤150mmHg(1.66[1.18-2.32],P=0.003)和 ECOG 评分≥1(1.42[1.00-2.02],P=0.050)。

结论

在土耳其 ICU 住院的 COVID-19 危重症患者中,长期死亡率较高。有创机械通气、乳酸水平、年龄、心律失常、血管加压素治疗、正性液体平衡、严重低氧血症和 ECOG 评分是 90 天死亡率的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90b4/8880837/92ec40480dde/bmj-38-5-296_f00S2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90b4/8880837/eea3bfcfc1ce/bmj-38-5-296_f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90b4/8880837/68f2eaca1106/bmj-38-5-296_f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90b4/8880837/ea4ac296bc11/bmj-38-5-296_f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90b4/8880837/94a56e5544c6/bmj-38-5-296_f00S1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90b4/8880837/92ec40480dde/bmj-38-5-296_f00S2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90b4/8880837/eea3bfcfc1ce/bmj-38-5-296_f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90b4/8880837/68f2eaca1106/bmj-38-5-296_f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90b4/8880837/ea4ac296bc11/bmj-38-5-296_f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90b4/8880837/94a56e5544c6/bmj-38-5-296_f00S1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90b4/8880837/92ec40480dde/bmj-38-5-296_f00S2.jpg

相似文献

1
Clinical Outcomes and Independent Risk Factors for 90-Day Mortality in Critically Ill Patients with Respiratory Failure Infected with SARS-CoV-2: A Multicenter Study in Turkish Intensive Care Units.COVID-19 相关呼吸衰竭危重症患者 90 天死亡率的临床转归和独立危险因素:土耳其重症监护室的多中心研究。
Balkan Med J. 2021 Sep;38(5):296-303. doi: 10.5152/balkanmedj.2021.21188.
2
Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.阿根廷 COVID-19 有创通气患者的临床特征和结局(SATICOVID):一项前瞻性、多中心队列研究。
Lancet Respir Med. 2021 Sep;9(9):989-998. doi: 10.1016/S2213-2600(21)00229-0. Epub 2021 Jul 2.
3
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.意大利伦巴第地区重症监护病房中 COVID-19 患者死亡的相关危险因素。
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539.
4
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
5
Clinical and therapeutic outcomes of COVID-19 intensive care units (ICU) patients: a retrospective study in Ghana.COVID-19 重症监护病房(ICU)患者的临床和治疗结果:加纳的一项回顾性研究。
Pan Afr Med J. 2021 Feb 2;38:107. doi: 10.11604/pamj.2021.38.107.27131. eCollection 2021.
6
Characteristics and outcomes of critically ill patients with covid-19 in Sakarya, Turkey: a single centre cohort study.土耳其萨卡里亚市新冠肺炎危重症患者的特征和结局:一项单中心队列研究。
Turk J Med Sci. 2021 Apr 30;51(2):440-447. doi: 10.3906/sag-2005-57.
7
Clinical Characteristics, Outcomes, and Risk Factors for Mortality in Pregnant/Puerperal Women with COVID-19 Admitted to ICU in Turkey: A Multicenter, Retrospective Study from a Middle-Income Country.土耳其 ICU 收治的 COVID-19 孕妇/产褥期妇女的临床特征、结局和死亡风险因素:来自中等收入国家的多中心回顾性研究。
J Intensive Care Med. 2024 Jun;39(6):577-594. doi: 10.1177/08850666231222838. Epub 2024 Feb 6.
8
Characteristics and Outcomes of COVID-19 Patients with Respiratory Failure Admitted to a "Pandemic Ready" Intensive Care Unit - Lessons from Singapore.收治于“抗疫准备充分”的重症监护病房的呼吸衰竭 COVID-19 患者的特征和结局——来自新加坡的经验教训。
Ann Acad Med Singap. 2020 Jul;49(7):434-448.
9
Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial.新冠肺炎合并中重度低氧血症呼吸衰竭患者使用头盔无创通气与高流量鼻导管吸氧治疗后脱机时间的影响:HENIVOT 随机临床试验
JAMA. 2021 May 4;325(17):1731-1743. doi: 10.1001/jama.2021.4682.
10
The modified NUTRIC score can be used for nutritional risk assessment as well as prognosis prediction in critically ill COVID-19 patients.改良的 NUTRIC 评分可用于危重症 COVID-19 患者的营养风险评估和预后预测。
Clin Nutr. 2021 Feb;40(2):534-541. doi: 10.1016/j.clnu.2020.05.051. Epub 2020 Jun 5.

引用本文的文献

1
Prognostic Factors in COVID-19 Patients with Ventilator-Associated Pneumonia: A Single-Centre Experience.新型冠状病毒肺炎合并呼吸机相关性肺炎患者的预后因素:单中心经验
Infect Dis Clin Microbiol. 2025 Jun 26;7(2):143-155. doi: 10.36519/idcm.2025.522. eCollection 2025 Jun.
2
Association of vasopressors with mortality in critically ill patients with COVID-19: a systematic review and meta-analysis.血管升压药与 COVID-19 危重症患者死亡率的关联:一项系统评价与荟萃分析
Anesthesiol Perioper Sci. 2023;1(2):10. doi: 10.1007/s44254-023-00013-7. Epub 2023 Apr 23.
3
Hypophosphatemia: Unraveling a lethal connection with icu mortality in critically ill COVID-19 patients: a multicenter observational study.

本文引用的文献

1
Long-term outcome after intensive care for COVID-19: differences between men and women-a nationwide cohort study.新冠肺炎患者重症监护的长期预后:男女之间的差异——一项全国性队列研究。
Crit Care. 2021 Feb 25;25(1):86. doi: 10.1186/s13054-021-03511-x.
2
Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.4244 例危重症 COVID-19 成年患者的临床特征和第 90 天结局:一项前瞻性队列研究。
Intensive Care Med. 2021 Jan;47(1):60-73. doi: 10.1007/s00134-020-06294-x. Epub 2020 Oct 29.
3
Outcomes of patients with COVID-19 in the intensive care unit in Mexico: A multicenter observational study.
低磷血症:揭示危重症COVID-19患者与ICU死亡率之间的致命关联:一项多中心观察性研究
J Med Biochem. 2025 Mar 21;44(2):330-338. doi: 10.5937/jomb0-52474.
4
Risk factors and predictive model for mortality in patients undergoing allogeneic hematopoietic stem cell transplantation admitted to the intensive care unit.入住重症监护病房的接受异基因造血干细胞移植患者死亡的危险因素及预测模型。
Exp Ther Med. 2024 Feb 27;27(4):168. doi: 10.3892/etm.2024.12457. eCollection 2024 Apr.
5
Ventilator associated pneumonia in COVID-19 patients: A retrospective cohort study.COVID-19 患者呼吸机相关性肺炎:一项回顾性队列研究。
Tuberk Toraks. 2023 Mar;71(1):41-47. doi: 10.5578/tt.20239906.
6
Rox Index Dynamics According to High Flow Nasal Cannula Success in Intensive Care Unit Patients with COVID-19-Related Acute Respiratory Failure.根据 COVID-19 相关急性呼吸衰竭的 ICU 患者高流量鼻导管治疗成功情况的罗克指数动态变化。
Balkan Med J. 2023 Mar 8;40(2):111-116. doi: 10.4274/balkanmedj.galenos.2022.2022-6-31. Epub 2023 Jan 30.
7
Management of COVID-19-Associated Acute Respiratory Failure with Alternatives to Invasive Mechanical Ventilation: High-Flow Oxygen, Continuous Positive Airway Pressure, and Noninvasive Ventilation.采用有创机械通气替代方法管理新型冠状病毒肺炎相关急性呼吸衰竭:高流量吸氧、持续气道正压通气和无创通气
Diagnostics (Basel). 2021 Dec 2;11(12):2259. doi: 10.3390/diagnostics11122259.
墨西哥重症监护病房 COVID-19 患者的结局:一项多中心观察性研究。
Heart Lung. 2021 Jan-Feb;50(1):28-32. doi: 10.1016/j.hrtlng.2020.10.013. Epub 2020 Oct 21.
4
A Higher Fluid Balance in the Days After Septic Shock Reversal Is Associated With Increased Mortality: An Observational Cohort Study.感染性休克逆转后数天内较高的液体平衡与死亡率增加相关:一项观察性队列研究。
Crit Care Explor. 2020 Sep 23;2(10):e0219. doi: 10.1097/CCE.0000000000000219. eCollection 2020 Oct.
5
COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland.COVID-19 重症监护中的情况:英格兰、威尔士和北爱尔兰首次疫情流行的流行病学。
Intensive Care Med. 2020 Nov;46(11):2035-2047. doi: 10.1007/s00134-020-06267-0. Epub 2020 Oct 9.
6
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.羟氯喹治疗 COVID-19 住院患者的疗效。
N Engl J Med. 2020 Nov 19;383(21):2030-2040. doi: 10.1056/NEJMoa2022926. Epub 2020 Oct 8.
7
Effects of fluid balance on prognosis of acute respiratory distress syndrome patients secondary to sepsis.液体平衡对脓毒症继发急性呼吸窘迫综合征患者预后的影响。
World J Emerg Med. 2020;11(4):216-222. doi: 10.5847/wjem.j.1920-8642.2020.04.003.
8
Challenges for the care delivery for critically ill COVID-19 patients in developing countries: the Brazilian perspective.发展中国家危重症 COVID-19 患者护理面临的挑战:巴西视角。
Crit Care. 2020 Sep 30;24(1):593. doi: 10.1186/s13054-020-03278-7.
9
Hospital preparedness and management of pediatric population during COVID-19 outbreak.新冠疫情期间医院对儿童群体的准备工作与管理
Ann Thorac Med. 2020 Jul-Sep;15(3):107-117. doi: 10.4103/atm.ATM_212_20. Epub 2020 Jun 18.
10
Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study.德国 1904 例 COVID-19 住院患者的临床病程和结局相关因素:一项观察性研究。
Clin Microbiol Infect. 2020 Dec;26(12):1663-1669. doi: 10.1016/j.cmi.2020.08.011. Epub 2020 Aug 18.